share_log

Tharimmune | 8-K: Current report

SEC announcement ·  Jun 12 04:22
Summary by Futu AI
Tharimmune, Inc., a biotechnology company incorporated in Delaware and listed on The Nasdaq Stock Market under the trading symbol THAR, has announced on June 11, 2024, that it has regained compliance with Nasdaq's minimum bid price requirement. This development follows a previous notification received by the company on June 12, 2023, from Nasdaq indicating that Tharimmune was not meeting the minimum bid price rule necessary for continued listing on The Nasdaq Capital Market. The company's compliance reinstatement ensures its continued listing and trading on the market.
Tharimmune, Inc., a biotechnology company incorporated in Delaware and listed on The Nasdaq Stock Market under the trading symbol THAR, has announced on June 11, 2024, that it has regained compliance with Nasdaq's minimum bid price requirement. This development follows a previous notification received by the company on June 12, 2023, from Nasdaq indicating that Tharimmune was not meeting the minimum bid price rule necessary for continued listing on The Nasdaq Capital Market. The company's compliance reinstatement ensures its continued listing and trading on the market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.